Recaticimab Biosimilar – Anti-PCSK9 mAb – Research Grade
Size | |
---|---|
Brand | |
Product type | |
Clonality | |
Expression system | |
Applications |
Product name | Recaticimab Biosimilar - Anti-PCSK9 mAb - Research Grade |
---|---|
Source | CAS 2361290-85-7 |
Species | Humanized |
Expression system | XtenCHO |
Purity | >85% |
Buffer | PBS buffer PH7.5 |
Delivery condition | Blue ice (+4°C) |
Delivery Time | 3-5 days if in stock; 3 week if production needed |
Storage condition | store at -80°C |
Brand | ProteoGenix |
Applications | ELISA,WB |
Aliases /Synonyms | Recaticimab,IMMUNOGLOBULIN G1-KAPPA, ANTI-(HOMO SAPIENSPCSK9 (PROPROTEIN CONVERTASE SUBTILISIN/KEXIN TYPE 9, NEURAL APOPTOSIS-REGULATED CONVERTASE 1, NARC1, NARC-1, PROPROTEINE CONVERTASE 9, PC9)), MONOCLONAL ANTIBODY (RECATICIMAB),PCSK9,anti-PCSK9 |
Reference | PX-TA1709 |
Note | For research use only. Not suitable for clinical or therapeutic use. |
Isotype | IgG1,Kappa |
Clonality | Monoclonal Antibody |
Related products
Contact us
Got a question or need a quote?
Message us and we’ll get back to you 48 hours or less.
Reviews
There are no reviews yet.